Similar Articles
Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China
Ke Zhang, Chunmei He, Qiaoting Deng, Wengen Li, Zhixiong Zhong, Jingyuan Hou
DOI: 10.46497/ArchRheumatol.2022.8870
Evaluation of personality disorders using the structured clinical interview for DSM-5 personality disorders, quality of life, and disease activity in patients with systemic lupus erythematosus
Yunus Durmaz, İlker İlhanlı, Pınar Durmaz
DOI: 10.46497/ArchRheumatol.2022.9002
Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study
Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee
DOI: 10.46497/ArchRheumatol.2022.9140
Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi
DOI: 10.46497/ArchRheumatol.2022.9217
Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience
Ferhat Demir, Eda Gürler, Betül Sözeri
DOI: 10.46497/ArchRheumatol.2022.8998
The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec
DOI: 10.46497/ArchRheumatol.2022.9255
MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis
Xinglan Huang, Peng Yan, Xinghua Song, Suiying Zhang, Yuqiong Deng, Caifeng Huang, Xiaoqing Zhao, Sheng Liu, Xiping Cheng, Dongjiang Liao
DOI: 10.46497/ArchRheumatol.2022.9168
The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients
Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed
DOI: 10.46497/ArchRheumatol.2022.9307
Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus
Yuewu Tang, Yi Luo
DOI: 10.46497/ArchRheumatol.2022.9167
Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?
Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin
DOI: 10.46497/ArchRheumatol.2022.9366
Association of pain and clinical factors on disability and quality of life in systemic sclerosis: A cross-sectional study from Turkish League Against Rheumatism Network
Remzi Çevik, Serda Em, Kemal Nas, Murat Toprak, Gizem Cengiz, Mustafa Çalış, İlhan Sezer, Ayşe Ünal Enginar, Pınar Bora Karslı, Sinem Sağ, Betül Sargın, Meltem Alkan Melikoğlu, Yıldıray Aydın, Mehmet Tuncay Duruöz, Halise Hande Gezer, Hilal Ecesoy
DOI: 10.46497/ArchRheumatol.2023.9243
Clinical course and prognostic factors of COVID-19 infection in patients with chronic inflammatory-rheumatic disease: A retrospective, case-control study
Kemal Nas, Ertuğrul Güçlü, Yaşar Keskin, Gamze Dilek, Mehtap Kalçık Unan, Nurselin Can, İbrahim Tekeoğlu, Ayhan Kamanlı
DOI: 10.46497/ArchRheumatol.2023.9289
Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up
Rasha N Yousef, Abeer Ramadan, Eman Awadallah, Alshaimaa R Alnaggar, Noha M Khalil, Mervat E.Behiry, Asmaa Ali, Hesham Gamal El Dine
DOI: 10.46497/ArchRheumatol.2023.9448
Patients with inflammatory myopathies overlapping with systemic sclerosis: A Brazilian-Japanese bicentric study
Jucier Gonçalves Júnior, Naoki Mugii, Pleiades Tiharu Inaoka, Renata Miossi, Fernando Henrique Carlos De Souza, João Calvino Soares De Oliveira, Fujiko Someya, Yasuhito Hamaguchi, Takashi Matsushita, Percival Degrava Sampaio-Barros, Samuel Katsuyuki Shinjo
DOI: 10.46497/ArchRheumatol.2023.9597
Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations
Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein
DOI: 10.46497/ArchRheumatol.2023.9638
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
DOI: 10.46497/ArchRheumatol.2023.9636
Analysis of risk factors for the progression and prognosis of connective tissue disease-associated interstitial lung disease
Ting Zhao, Fu-an Lin, Hongpu Chen
DOI: 10.46497/ArchRheumatol.2023.9602
Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis
Fulden Sari, Zilan Bazancir Apaydin, Hakan Apaydin, Mehmet Kayaalp, Abdulsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, Orhan Kucuksahin, Şükran Erten
DOI: 10.46497/ArchRheumatol.2023.10183
Clinical association study on the matrix metalloproteinase expression in the serum of patients with connective tissue disease complicated with interstitial lung disease
Hong Chen*, Jun Tang*, Juhua Liang, Dan Huang, Chunfeng Pan, Sha Liu, Xiuri Du, Liju Tao
DOI: 10.46497/ArchRheumatol.2023.9547
Association between levels of serum and urinary B cell-activating factor and systemic lupus erythematosus disease activity
Maryam Rezazadeh, Mohammad Hasan Jokar, Seyedeh Mehrnaz Aghili, Zahra Mirfeizi, Mahmoud Mahmoudi, Negar Morovatdar, Kamila Hashemzadeh
DOI: 10.46497/ArchRheumatol.2023.9549